Pancreatic cancer vaccine shows promise

Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer recurring in patients who initially respond.
Vaccine shows promise for pancreatic cancer, study finds
Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.
A Vaccine For Pancreatic Cancer Continues To Show Promise
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.
STAT2d
The ironic origin story behind Sloan Kettering
Sloan Kettering is one of the world’s leading cancer centers. It was founded by two men who created and sold leaded gasoline ...
It's a Miracle! Cancer center event gets cynical New Yorkers to agree on something
Proceeds from sales at participating 'Miracle in Palm Beach' stores benefit MSK Kids, the pediatric program at Memorial Sloan ...
Becker's Hospital Review4d
Memorial Sloan Kettering, Amazon partner on cancer innovation
New York City-based Memorial Sloan Kettering Cancer Center has partnered with Amazon Web Services to accelerate cancer innovation and research through AI, high-performance computing and cloud ...
MedCity News6d
Memorial Sloan Kettering Teams Up with AWS to Speed Up Drug Discovery
For instance, AI can examine patient data to predict the likelihood of developing certain diseases and the associated trajectory of disease burden, which allows for early interventions and ...
AWS expands AI in healthcare through a Memorial Sloan Kettering partnership
Amazon Web Services ( AMZN) has been increasing its partnerships with health companies to advance AI capabilities in ...
Experimental vaccine for common cancer shows potential in clinical trial; here’s what we know
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...